Asarfi Hospital Ltd.
BSE: ASARFI
Prev Close
139
Open Price
140.4
Volume
4,000
Today Low / High
139.55 / 141.5
52 WK Low / High
52.84 / 145.8
Range
134 - 148
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 140.7, reflecting a change of 1.7 (1.22302%). The expected target range on the BSE is 134 - 148. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Asarfi Hospital Ltd. Graph
Asarfi Hospital Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Asarfi Hospital Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 140.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 140.70 | 142.11 | 127.90 - 156.32 |
| 143.51 | 114.81 - 172.22 | ||
| 144.92 | 101.44 - 188.40 | ||
| Bearish Scenario | 140.70 | 139.29 | 125.36 - 153.22 |
| 137.89 | 110.31 - 165.46 | ||
| 136.48 | 95.54 - 177.42 |
Overview of Asarfi Hospital Ltd.
ISIN
INE0DN001027
Industry
Medical - Care Facilities
Vol.Avg
54,116
Market Cap
2,762,692,920
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 120.57 Cr | 27.86 Cr | 92.71 Cr | 0.7689 | 0.00 Cr | 0.00 Cr | 10.87 Cr | 10.58 Cr | 5.36 | 31.07 Cr | 0.0877 |
| 2024-03-31 | 84.40 Cr | 20.33 Cr | 64.07 Cr | 0.7591 | 0.00 Cr | 15.15 Cr | 7.42 Cr | 4.16 Cr | 2.31 | 17.47 Cr | 0.0493 |
| 2023-03-31 | 70.70 Cr | 33.92 Cr | 36.78 Cr | 0.5202 | 0.00 Cr | 0.01 Cr | 9.90 Cr | 8.02 Cr | 7.58 | 13.77 Cr | 0.1134 |
| 2022-03-31 | 65.21 Cr | 35.74 Cr | 29.47 Cr | 0.4519 | 0.00 Cr | 0.03 Cr | 7.44 Cr | 5.73 Cr | 7.64 | 10.79 Cr | 0.0878 |
| 2021-03-31 | 54.12 Cr | 31.63 Cr | 22.49 Cr | 0.4156 | 0.00 Cr | 0.30 Cr | 5.12 Cr | 3.53 Cr | 4.71 | 8.04 Cr | 0.0653 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.43 Cr | 163.89 Cr | 82.90 Cr | 80.9832 Cr | 48.56 Cr | 47.13 Cr | 2.28 Cr | 103.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 41.0392 Cr |
| 2024-03-31 | 17.60 Cr | 154.09 Cr | 83.68 Cr | 70.4070 Cr | 31.91 Cr | 14.32 Cr | 1.80 Cr | 93.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 41.4797 Cr |
| 2023-03-31 | 8.52 Cr | 93.43 Cr | 51.58 Cr | 41.8426 Cr | 17.20 Cr | 8.68 Cr | 1.42 Cr | 56.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 19.5902 Cr |
| 2022-03-31 | 13.72 Cr | 62.70 Cr | 40.08 Cr | 22.6273 Cr | 11.63 Cr | -2.09 Cr | 1.09 Cr | 40.21 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 14.7630 Cr |
| 2021-03-31 | 6.75 Cr | 37.29 Cr | 20.40 Cr | 16.8990 Cr | 7.13 Cr | 0.38 Cr | 0.82 Cr | 24.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 8.6324 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -4.3498 Cr | -7.3839 Cr | 12.5688 Cr | -16.1370 Cr | 0.8351 Cr | 1.4263 Cr | -11.7872 Cr | 10.5762 Cr | 16.6451 Cr | 0.0000 Cr | -0.4768 Cr |
| 2024-03-31 | 26.0741 Cr | -63.0899 Cr | 36.4068 Cr | -19.9998 Cr | -0.6090 Cr | 0.6952 Cr | -46.0739 Cr | 4.1616 Cr | 14.7102 Cr | 0.0000 Cr | -0.3752 Cr |
| 2023-03-31 | -2.0652 Cr | -13.6462 Cr | 16.8155 Cr | -22.2058 Cr | 1.1041 Cr | 1.3042 Cr | -20.1406 Cr | 8.0153 Cr | 6.9542 Cr | 0.0000 Cr | -0.3334 Cr |
| 2022-03-31 | 9.2648 Cr | -23.1612 Cr | 13.7686 Cr | -10.2534 Cr | -0.1278 Cr | 0.2001 Cr | -19.5182 Cr | 5.7284 Cr | 14.4705 Cr | 0.0000 Cr | -0.2725 Cr |
| 2021-03-31 | 10.2948 Cr | -16.0026 Cr | 5.9995 Cr | 1.9332 Cr | 0.2916 Cr | 0.3279 Cr | -8.3616 Cr | 3.5343 Cr | 6.6265 Cr | 0.0000 Cr | -0.3978 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 32.89 Cr | 7.18 Cr | 25.71 Cr | 0.7817 | 3.90 Cr | 2.68 Cr | 1.36 | 7.85 Cr | 0.0816 |
| 2024-12-31 | 32.89 Cr | 7.18 Cr | 25.71 Cr | 0.7817 | 3.90 Cr | 2.68 Cr | 1.36 | 7.85 Cr | 0.0816 |
| 2024-03-31 | 22.04 Cr | 9.50 Cr | 12.54 Cr | 0.5691 | 11.27 Cr | 1.05 Cr | 0.43 | 4.11 Cr | 0.0475 |
| 2024-03-31 | 22.04 Cr | 9.50 Cr | 12.54 Cr | 0.5691 | 11.27 Cr | 1.05 Cr | 0.43 | 4.11 Cr | 0.0475 |
| 2023-12-31 | 22.04 Cr | 9.22 Cr | 12.82 Cr | 0.5817 | 1.78 Cr | 1.05 Cr | 0.43 | 3.98 Cr | 0.0475 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 21.25 Cr | 0.00 Cr | 21.25 Cr | 36.12 Cr | 2.27 Cr | 59.78 Cr | 105.18 Cr | 165.50 Cr | 88.10 Cr |
| 2024-12-31 | 21.25 Cr | 0.00 Cr | 21.25 Cr | 36.12 Cr | 2.27 Cr | 59.78 Cr | 105.18 Cr | 165.50 Cr | 88.10 Cr |
| 2024-09-30 | 19.67 Cr | 0.00 Cr | 19.67 Cr | 0.00 Cr | 1.95 Cr | 54.71 Cr | 89.91 Cr | 158.14 Cr | 83.62 Cr |
| 2024-03-31 | 17.60 Cr | 0.00 Cr | 17.60 Cr | 24.26 Cr | 1.80 Cr | 46.75 Cr | 93.77 Cr | 154.09 Cr | 83.68 Cr |
| 2024-03-31 | 17.60 Cr | 0.00 Cr | 17.60 Cr | 24.26 Cr | 1.80 Cr | 46.75 Cr | 93.77 Cr | 154.09 Cr | 83.68 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 2.68 Cr | 5.72 Cr | -5.01 Cr | -0.34 Cr | 0.37 Cr | 2.67 Cr | 2.31 Cr | -5.03 Cr | 0.69 Cr |
| 2024-03-31 | 1.05 Cr | 0.42 Cr | -0.17 Cr | -2.48 Cr | -2.24 Cr | -2.24 Cr | 0.00 Cr | -0.08 Cr | 0.34 Cr |
| 2024-03-31 | 1.05 Cr | 0.42 Cr | -0.17 Cr | -2.48 Cr | -2.24 Cr | -2.24 Cr | 0.00 Cr | -0.08 Cr | 0.34 Cr |
| 2023-12-31 | 1.05 Cr | 0.42 Cr | -0.17 Cr | -2.48 Cr | -2.24 Cr | -2.24 Cr | 0.00 Cr | -0.08 Cr | 0.34 Cr |
| 2023-09-30 | 1.03 Cr | 12.62 Cr | -31.37 Cr | 20.69 Cr | 1.93 Cr | 1.93 Cr | 0.00 Cr | -22.96 Cr | -10.34 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,298.20 | ₹1,262,041,235,400.00 | ₹1,062,167.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,553.50 | ₹1,086,079,997,500.00 | ₹348,970.00 |
| Fortis Healthcare Limited | FORTIS | ₹807.05 | ₹609,288,853,900.00 | ₹1,071,334.00 |
| Narayana Hrudayalaya Limited | NH | ₹2,011.40 | ₹411,051,715,400.00 | ₹427,274.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹633.15 | ₹328,048,311,150.00 | ₹4,438,813.00 |
| Global Health Limited | MEDANTA | ₹1,183.80 | ₹317,953,728,606.00 | ₹135,543.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹686.05 | ₹274,515,360,950.00 | ₹1,189,218.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,599.40 | ₹162,421,747,396.00 | ₹354,790.00 |
| HealthCare Global Enterprises Limited | HCG | ₹566.30 | ₹78,950,714,500.00 | ₹666,784.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹575.35 | ₹55,437,478,149.00 | ₹316,699.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹505.75 | ₹46,363,619,750.00 | ₹523,962.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹256.95 | ₹35,690,355,000.00 | ₹211,229.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: female
Year Born: 1973
Gender: male
Year Born: 1994
Gender: male
Year Born: 1974
Gender: male
Year Born:
FAQs about Asarfi Hospital Ltd.
The CEO is Udai Pratap Singh.
The current price is ₹140.40.
The range is ₹52.84-145.8.
The market capitalization is ₹276.27 crores.
The P/E ratio is 37.14.
The company operates in the Healthcare sector.
Overview of Asarfi Hospital Ltd. (ISIN: INE0DN001027) is a leading Medical - Care Facilities in India. With a market capitalization of ₹276.27 crores and an average daily volume of 54,116 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.